
    
      A Phase I, Single Centre, Randomised, Double-blind, Placebo-controlled Parallel Group Study
      to Assess the Safety, Tolerability, and Pharmacokinetics of Ceftaroline after Different
      Intravenous Dose Regimens of Ceftaroline Fosamil to Healthy Subjects
    
  